康惠制药 (603139.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(康惠制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 202,931,449.18145,504,766.58123,792,050.57116,370,406.64132,118,911.52125,291,971.53117,729,916.33
 营业收入(元) 202,931,449.18145,504,766.58123,792,050.57116,370,406.64132,118,911.52125,291,971.53117,729,916.33
二、营业总成本(元) 209,273,210.49142,496,773.13118,797,207.65126,146,461.65134,049,635.49122,122,113.62106,722,145.56
 营业成本(元) 154,183,788.9198,142,835.4280,979,718.3171,892,918.7077,160,920.6876,464,850.2166,847,904.27
 研发费用(元) 3,205,173.162,295,761.161,982,426.702,511,191.485,716,123.342,672,156.021,445,540.79
 营业税金及附加(元) 1,373,179.671,070,315.13863,797.581,124,239.10630,540.24696,586.01722,905.43
 销售费用(元) 30,382,053.2929,783,322.4926,671,890.4235,479,960.6442,320,482.0931,713,000.5828,668,686.89
 管理费用(元) 11,379,297.8211,030,602.517,724,781.4610,818,596.077,282,738.899,125,947.087,906,760.00
 财务费用(元) 8,749,717.64173,936.43574,593.184,319,555.66938,830.251,449,573.721,130,348.18
  其中:利息费用(元) 10,195,980.021,700,823.812,423,942.026,701,217.612,165,334.352,378,947.801,972,180.10
  其中:利息收入(元) 1,673,540.651,717,528.061,738,358.612,055,658.121,645,128.331,009,182.47907,978.72
 资产减值损失(元) 218,250.032,297,905.21-146,092.87----
 信用减值损失(元) -5,565,910.94-1,468,635.063,783,094.40-6,724,719.62-368,357.79-437,061.59-2,239,461.45
三、其他经营收益
 加:公允价值变动收益(元) -72,058.50------
 加:投资收益(元) 2,304,895.03-1,274,915.205,112.67-16,183,856.274,312,439.752,770,808.312,064,155.78
  其中:对联营企业和合营企业的投资收益(元) ----16,199,912.512,796,254.23449,206.611,245,519.32
 资产处置收益(元) ----9,890.47---
 其他收益(元) 539,079.29266,432.53214,804.98-832,246.92450,129.12816,612.65586,621.19
四、营业利润(元) -8,917,506.402,872,332.678,851,762.10-95,884,134.322,463,487.116,310,148.3111,419,086.29
 加:营业外收入(元) 16,268.35-70,144.3395,528.01-106,569.56127,429.27-7,030.2257,744.73
 减:营业外支出(元) 12,814.92114,554.00558.316,680,720.01248,432.10-20,188.13213,379.46
五、利润总额(元) -8,914,052.972,687,634.348,946,731.80-102,671,423.892,342,484.286,323,306.2211,263,451.56
 减:所得税费用(元) -1,092,064.652,041,045.42665,392.64-9,755,017.861,332,246.61355,475.652,109,811.56
六、净利润(元) -7,821,988.31646,588.918,281,339.16-92,916,406.031,010,237.675,967,830.579,153,640.00
(一)按经营持续性分类
  持续经营净利润(元) -7,821,988.31646,588.918,281,339.16-92,916,406.031,010,237.675,967,830.579,153,640.00
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -3,377,492.684,392,807.568,206,330.75-79,320,558.932,339,881.005,132,799.618,791,930.72
  少数股东损益(元) -4,444,495.63-3,746,218.6575,008.41-13,595,847.10-1,329,643.33835,030.96361,709.28
 扣除非经常性损益后的净利润(元) -6,729,675.764,269,090.858,016,925.33-77,806,104.06843,099.262,608,511.217,837,432.34
七、每股收益
 一、基本每股收益(元) -0.040.050.08-0.790.020.050.09
 二、稀释每股收益(元) -0.040.050.08-0.790.020.050.09
九、综合收益总额(元) -7,821,988.31646,588.918,281,339.16-95,421,960.301,010,237.675,967,830.579,153,640.00
 归属于母公司所有者的综合收益总额(元) -3,377,492.684,392,807.568,206,330.75-81,826,113.202,339,881.005,132,799.618,791,930.72
 归属于少数股东的综合收益总额(元) -4,444,495.63-3,746,218.6575,008.41-13,595,847.10-1,329,643.33835,030.96361,709.28
公告日期 2023-10-282023-08-312023-04-292023-04-292022-10-262022-08-202022-04-29
审计意见(境内) 保留意见

前瞻产业研究院